EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.

Source:http://linkedlifedata.com/resource/pubmed/id/15329413

Proc. Natl. Acad. Sci. U.S.A. 2004 Sep 7 101 36 13306-11

Download in:

View as

Triples

General Info

PMID
15329413